Diabetes Care
29:1357-1362,
2006
DOI: 10.2337/dc05-1801
© 2006 by the American Diabetes Association
Cardiovascular and Metabolic Risk Original Article |
Measurement of the HighMolecular Weight Form of Adiponectin in Plasma Is Useful for the Prediction of Insulin Resistance and Metabolic Syndrome
Kazuo Hara, MD, PHD1,2,
Momoko Horikoshi, MD, PHD1,2,
Toshimasa Yamauchi, MD, PHD1,2,
Hirokazu Yago3,
Osamu Miyazaki3,
Hiroyuki Ebinuma3,
Yasushi Imai, MD, PHD4,5,
Ryozo Nagai, MD, PHD4,5 and
Takashi Kadowaki, MD, PHD1,2
1 Department of Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
2 Core Research for Evolutional Science and Technology, Japan Science and Technology, Tokyo, Japan
3 Diagnostics Research Laboratories, Daiichi Pure Chemicals, Ibaraki, Japan
4 Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
5 Department of Clinical Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
Address correspondence and reprint requests to Dr. Takashi Kadowaki, Department of Metabolic Diseases, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. E-mail: kadowaki-3im{at}h.u-tokyo.ac.jp
OBJECTIVEThe highmolecular weight (HMW) form of adiponectin, an adipocyte-derived insulin-sensitizing hormone, has been reported to be the most active form of this hormone. We investigated whether measurement of plasma HMW adiponectin levels, using our newly developed enzyme-linked immunosorbent assay system for selective measurement of human HMW adiponectin level, may be useful for the prediction of insulin resistance and metabolic syndrome.
RESEARCH DESIGN AND METHODSA total of 298 patients admitted for diabetes treatment or coronary angiography served as study subjects. Receiver operator characteristic (ROC) curves for the HMW ratio (HMWR; ratio of plasma level of HMW adiponectin to that of total adiponectin) and plasma total adiponectin levels were plotted to predict the presence of insulin resistance and metabolic syndrome.
RESULTSThe area under the ROC curve (AUC) of the HMWR values to predict the presence of insulin resistance was significantly larger than that of plasma total adiponectin level in total subjects (0.713 [95% CI 0.6200.805] vs. 0.615 [0.5220.708], P = 0.0160). The AUC for the HMWR values to predict the presence of metabolic syndrome was significantly larger than that for plasma total adiponectin levels in men (0.806 [0.7470.865] vs. 0.730 [0.6600.800], P = 0.0025) and in women (0.743 [0.6590.828] vs. 0.637 [0.5320.742], P = 0.0458).
CONCLUSIONSThe HMWR value has better predictive power for the prediction of insulin resistance and metabolic syndrome than plasma total adiponectin level.
Abbreviations: AUC, area under the curve HMW, high molecular weight HMWR, HMW ratio HOMA-IR, homeostasis model assessment of insulin resistance IDF, International Diabetes Federation ROC, receiver operator characteristic

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. L Fargnoli, T. T Fung, D. M Olenczuk, J. P Chamberland, F. B Hu, and C. S Mantzoros
Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses' Health Study
Am. J. Clinical Nutrition,
November 1, 2008;
88(5):
1213 - 1224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Heidemann, Q. Sun, R. M. van Dam, J. B. Meigs, C. Zhang, S. S. Tworoger, C. S. Mantzoros, and F. B. Hu
Total and High-Molecular-Weight Adiponectin and Resistin in Relation to the Risk for Type 2 Diabetes in Women
Ann Intern Med,
September 2, 2008;
149(5):
307 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-F. Hivert, L. M. Sullivan, C. S. Fox, D. M. Nathan, R. B. D'Agostino Sr., P. W. F. Wilson, and J. B. Meigs
Associations of Adiponectin, Resistin, and Tumor Necrosis Factor-{alpha} with Insulin Resistance
J. Clin. Endocrinol. Metab.,
August 1, 2008;
93(8):
3165 - 3172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Pinar, S. Basu, K. Hotmire, L. Laffineuse, L. Presley, M. Carpenter, P. M. Catalano, and S. Hauguel-de Mouzon
High Molecular Mass Multimer Complexes and Vascular Expression Contribute to High Adiponectin in the Fetus
J. Clin. Endocrinol. Metab.,
July 1, 2008;
93(7):
2885 - 2890.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Peterlin, G. Alexander, D. Tabby, and E. Reichenberger
Oligomerization state-dependent elevations of adiponectin in chronic daily headache
Neurology,
May 13, 2008;
70(20):
1905 - 1911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. von Eynatten, A. Hamann, D. Twardella, P. P. Nawroth, H. Brenner, and D. Rothenbacher
Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease
Eur. Heart J.,
May 2, 2008;
29(10):
1307 - 1315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sattar, P. Watt, L. Cherry, S. Ebrahim, G. Davey Smith, and D. A. Lawlor
High Molecular Weight Adiponectin Is Not Associated with Incident Coronary Heart Disease in Older Women: A Nested Prospective Case-Control Study
J. Clin. Endocrinol. Metab.,
May 1, 2008;
93(5):
1846 - 1849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Schraw, Z. V. Wang, N. Halberg, M. Hawkins, and P. E. Scherer
Plasma Adiponectin Complexes Have Distinct Biochemical Characteristics
Endocrinology,
May 1, 2008;
149(5):
2270 - 2282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Saito, N. Yamaguchi, Y. Shimazaki, H. Hayashida, K. Yonemoto, Y. Doi, Y. Kiyohara, M. Iida, and Y. Yamashita
Serum Levels of Resistin and Adiponectin in Women with Periodontitis: the Hisayama Study
J. Dent. Res.,
April 1, 2008;
87(4):
319 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Kosmiski, P. Bacchetti, D. P. Kotler, S. B. Heymsfield, C. E. Lewis, M. G. Shlipak, R. Scherzer, and C. Grunfeld
Relationship of Fat Distribution with Adipokines in Human Immunodeficiency Virus Infection
J. Clin. Endocrinol. Metab.,
January 1, 2008;
93(1):
216 - 224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Sinha, T. Songer, Q. Xiao, J. H. Sloan, J. Wang, S. Ji, W. E. Alborn, R. A. Davis, M. M. Swarbrick, K. L. Stanhope, et al.
Analytical Validation and Biological Evaluation of a High Molecular-Weight Adiponectin ELISA
Clin. Chem.,
December 1, 2007;
53(12):
2144 - 2151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, R. Retnakaran, A. Hanley, R. Tungtrongchitr, C. Shaw, and G. Sweeney
Total and High Molecular Weight But Not Trimeric or Hexameric Forms of Adiponectin Correlate with Markers of the Metabolic Syndrome and Liver Injury in Thai Subjects
J. Clin. Endocrinol. Metab.,
November 1, 2007;
92(11):
4313 - 4318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Basu, U. B. Pajvani, R. A. Rizza, and P. E. Scherer
Selective Downregulation of the High Molecular Weight Form of Adiponectin in Hyperinsulinemia and in Type 2 Diabetes: Differential Regulation From Nondiabetic Subjects
Diabetes,
August 1, 2007;
56(8):
2174 - 2177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ebinuma, T. Miida, T. Yamauchi, Y. Hada, K. Hara, N. Kubota, and T. Kadowaki
Improved ELISA for Selective Measurement of Adiponectin Multimers and Identification of Adiponectin in Human Cerebrospinal Fluid
Clin. Chem.,
August 1, 2007;
53(8):
1541 - 1544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. von Eynatten, P. M. Lepper, and P. M. Humpert
Total and High-Molecular Weight Adiponectin in Relation to Metabolic Variables at Baseline and in Response to an Exercise Treatment Program: Comparative Evaluation of Three Assays: Response to Bluher et al.
Diabetes Care,
July 1, 2007;
30(7):
e67 - e67.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lo, L. E. Bernstein, B. Canavan, M. Torriani, M. B. Jackson, R. S. Ahima, and S. K. Grinspoon
Effects of TNF-{alpha} neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome
Am J Physiol Endocrinol Metab,
July 1, 2007;
293(1):
E102 - E109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ikeda, H. Takata, K. Inoue, M. Shinahara, S. Inada, H. Maruyama, F. Osaki, T. Suehiro, and K. Hashimoto
Pioglitazone Rapidly Increases Serum Adiponectin Levels in Men With Normal Glucose Tolerance
Diabetes Care,
June 1, 2007;
30(6):
e48 - e48.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Modan-Moses, D. Stein, C. Pariente, A. Yaroslavsky, A. Ram, M. Faigin, R. Loewenthal, E. Yissachar, R. Hemi, and H. Kanety
Modulation of Adiponectin and Leptin during Refeeding of Female Anorexia Nervosa Patients
J. Clin. Endocrinol. Metab.,
May 1, 2007;
92(5):
1843 - 1847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Wiecek, M. Adamczak, and J. Chudek
Adiponectin--an adipokine with unique metabolic properties
Nephrol. Dial. Transplant.,
April 1, 2007;
22(4):
981 - 988.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hattori, S. Hattori, K. Akimoto, T. Nishikimi, K. Suzuki, H. Matsuoka, and K. Kasai
Globular Adiponectin Activates Nuclear Factor-{kappa}B and Activating Protein-1 and Enhances Angiotensin II-Induced Proliferation in Cardiac Fibroblasts
Diabetes,
March 1, 2007;
56(3):
804 - 808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Kraemer and V. D. Castracane
Exercise and Humoral Mediators of Peripheral Energy Balance: Ghrelin and Adiponectin
Experimental Biology and Medicine,
February 1, 2007;
232(2):
184 - 194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bluher, A. M. Brennan, T. Kelesidis, J. Kratzsch, M. Fasshauer, S. Kralisch, C. J. Williams, and C. S. Mantzoros
Total and High-Molecular Weight Adiponectin in Relation to Metabolic Variables at Baseline and in Response to an Exercise Treatment Program: Comparative evaluation of three assays
Diabetes Care,
February 1, 2007;
30(2):
280 - 285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Trujillo and P. E. Scherer
Adipose Tissue-Derived Factors: Impact on Health and Disease
Endocr. Rev.,
December 1, 2006;
27(7):
762 - 778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Araki, K. Dobashi, K. Kubo, K. Asayama, and A. Shirahata
High Molecular Weight, Rather than Total, Adiponectin Levels Better Reflect Metabolic Abnormalities Associated with Childhood Obesity
J. Clin. Endocrinol. Metab.,
December 1, 2006;
91(12):
5113 - 5116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Katsuki, M. Suematsu, E. C. Gabazza, S. Murashima, K. Nakatani, K. Togashi, Y. Yano, and Y. Sumida
Decreased High-Molecular Weight Adiponectin-to-Total Adiponectin Ratio in Sera Is Associated With Insulin Resistance in Japanese Metabolically Obese, Normal-Weight Men With Normal Glucose Tolerance
Diabetes Care,
October 1, 2006;
29(10):
2327 - 2328.
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Diabetes Association.
|
|
| |
|